Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Myriad Genetics Inc., 3 years.
Myriad Genetics Inc.
Director
Coherus Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Coherus Oncology Inc. | Grant or award | +30,000 | — | — |
| Jun 4, 2026 | Myriad Genetics Inc. | Grant or award | +59,701 | — | — |
| Jun 5, 2025 | Myriad Genetics Inc. | Grant or award | +49,796 | — | — |
| Jun 6, 2024 | Myriad Genetics Inc. | Grant or award | +15,695 | — | — |
| May 13, 2024 | Myriad Genetics Inc. | Open-market sale | −6,200 | $25.30 | $156,860 |
| Jun 1, 2023 | Myriad Genetics Inc. | Grant or award | +15,151 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.